| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
|
Monda, Vincenzo M.
|
|
|
11 |
9 |
p. 1909-1914
|
article
|
| 2 |
Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
|
Williams, David M.
|
|
|
11 |
9 |
p. 1925-1934
|
article
|
| 3 |
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
|
Kalra, Sanjay
|
|
|
11 |
9 |
p. 1965-1982
|
article
|
| 4 |
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
|
Attri, Bhawna
|
|
|
11 |
9 |
p. 2177-2194
|
article
|
| 5 |
Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis
|
Shrestha, Nipun
|
|
|
11 |
9 |
p. 1935-1946
|
article
|
| 6 |
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
|
Cho, Yun Kyung
|
|
|
11 |
9 |
p. 2029-2039
|
article
|
| 7 |
Diabetes and Novel Coronavirus Infection: Implications for Treatment
|
Williams, David M.
|
|
|
11 |
9 |
p. 1915-1924
|
article
|
| 8 |
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
|
Hinton, William
|
|
|
11 |
9 |
p. 2169-2175
|
article
|
| 9 |
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies
|
Alshnbari, Afnan S.
|
|
|
11 |
9 |
p. 1947-1963
|
article
|
| 10 |
Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes
|
Zhang, Yali
|
|
|
11 |
9 |
p. 2057-2073
|
article
|
| 11 |
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results
|
Tong, Xue
|
|
|
11 |
9 |
p. 1983-1999
|
article
|
| 12 |
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy
|
Gentile, Sandro
|
|
|
11 |
9 |
p. 2001-2017
|
article
|
| 13 |
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
|
Ramos, Mafalda
|
|
|
11 |
9 |
p. 2041-2055
|
article
|
| 14 |
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
|
Giorda, Carlo Bruno
|
|
|
11 |
9 |
p. 2105-2119
|
article
|
| 15 |
Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population
|
Hu, Yun
|
|
|
11 |
9 |
p. 2019-2027
|
article
|
| 16 |
Role of FTO and MC4R Polymorphisms in Escalating Obesity and Their Indirect Association With Risk of T2D in Indian Population
|
Khan, Shahbaz
|
|
|
11 |
9 |
p. 2145-2157
|
article
|
| 17 |
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
|
He, Liyun
|
|
|
11 |
9 |
p. 2121-2143
|
article
|
| 18 |
Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
|
de Valk, Harold W.
|
|
|
11 |
9 |
p. 2159-2167
|
article
|
| 19 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
|
Jinnouchi, Hideaki
|
|
|
11 |
9 |
p. 2075-2088
|
article
|
| 20 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
|
Miura, Junnosuke
|
|
|
11 |
9 |
p. 2089-2104
|
article
|
Journal description